Internal Medicine, Gastroenterology · Midland, TX
NPI
1073555249
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4214 Andrews Hwy, Suite 203
Midland, TX, 79703
Phone (432) 697-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$144K
1,710 services
Medicare patients, 2024
850
Average age 71
Drug cost, 2024
$179K
1,719 prescriptions
Company payments, 2025
$753
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Govind B Patel was code 99213 (office e&m - established), 430 times for 338 patients. In total Govind B Patel billed 1,710 services in 34 codes, and Medicare paid $144K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-12-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 430 | 338 | $54.24 | $23K |
| 99203 Office E&M - New | Office | 333 | 333 | $57.71 | $19K |
| 45385 Colonoscopy - Lesion Removal | Facility | 256 | 256 | $173.73 | $44K |
| 99212 Office E&M - Established | Office | 166 | 144 | $36.22 | $6,012 |
| 43239 Upper GI Endoscopy | Facility | 149 | 142 | $64.65 | $9,633 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 129 | 129 | $160.05 | $21K |
| 99202 Office E&M - New | Office | 58 | 58 | $39.96 | $2,318 |
| 45380 Lower GI Endoscopy - Other | Facility | 46 | 46 | $59.54 | $2,739 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 33 | 33 | $160.46 | $5,295 |
| 43235 Upper GI Endoscopy | Facility | 25 | 25 | $55.40 | $1,385 |
| 43251 Upper GI Endoscopy | Facility | 20 | 20 | $105.09 | $2,102 |
| 45378 Lower GI Endoscopy - Other | Facility | 11 | 11 | $128.72 | $1,416 |
| 43249 Upper GI Endoscopy | Facility | 11 | 11 | $80.85 | $889 |
By year: 2022 $131K for 1,582 services; 2023 $123K for 1,395 services; 2024 $144K for 1,710 services.
Medicare prescription drug claims, 2024
In 2024, the drug Govind B Patel prescribed most often to Medicare patients was Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg), with 560 prescriptions and refills. In total Govind B Patel wrote 1,719 Medicare prescriptions that cost $179K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 560 | 560 | 556 | $13K |
| Omeprazole Generic | 387 | 901 | 119 | $4,898 |
| Pantoprazole Sodium Generic | 167 | 461 | 63 | $2,086 |
| Ursodiol Generic | 34 | 50 | Under 11 | $6,811 |
| Sucralfate Generic | 33 | 39 | 17 | $524 |
| Esomeprazole Magnesium Generic | 33 | 72 | Under 11 | $787 |
| Azathioprine Generic | 29 | 69 | Under 11 | $2,085 |
| Mesalamine Generic | 25 | 61 | Under 11 | $14K |
| Dexlansoprazole Dr Dexlansoprazole | 24 | 35 | Under 11 | $7,197 |
| Ondansetron Odt Ondansetron | 24 | 36 | Under 11 | $598 |
| Lansoprazole Generic | 24 | 40 | 19 | $403 |
| Famotidine Generic | 22 | 44 | Under 11 | $297 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 21 | 21 | 20 | $349 |
| Mesalamine Er Mesalamine | 21 | 51 | Under 11 | $11K |
| Sulfasalazine Generic | 20 | 37 | Under 11 | $523 |
Brand drugs: 244 claims; generic drugs: 1,475 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Govind B Patel $753 ($753 in general payments such as food, travel and fees) from 11 companies. The largest payer was Janssen Biotech, Inc. with $135.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 10 | $135 |
| Abbvie Inc. ABBV | 6 | $113 |
| Pfizer Inc. PFE | 4 | $97.82 |
| Gilead Sciences, Inc. GILD | 3 | $83.22 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $78.12 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 3 | $61.95 |
| Ardelyx, Inc. ARDX | 2 | $58.7 |
| Genzyme Corporation SNY | 2 | $54.6 |
| Intercept Pharmaceuticals, Inc. | 2 | $37.51 |
| Lilly USA, LLC LLY | 1 | $23.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.